1. health and fitness

Brain Tumor Treatment
Market
Share, Global Trends,
Analysis, Research, Report,
Opportunities,
Segmentation and Forecast,
2016
Future Market Insights
www.futuremarketinsights.com
[email protected]
Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,
technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and
Retail.
We have a global presence with delivery centers across India specializing in providing global research reports and country
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.
We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for
our client.
Research Capabilities
Sector Coverage








Customized Research
Syndicated Research
Investment Research
Social Media Research
Automotive and Transportation
Electronics, Semiconductor, and ICT
Retail and Consumer Products
Industrial Automation and Equipment
Customized
Research
Subscription Information
Syndicated
Research
For detailed subscription information please contact
Investment
Research
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268
Social Media
Research
Hari. T (Sr. Manager - Global Business Development)
Email: [email protected]




Chemicals & Materials
Food and Beverages
Services and Utilities
Energy, Mining, Oil, and Gas
Report
Description
Report Description
A brain tumor is an abnormal and uncontrolled proliferation of cells in the brain. It can be
benign or malignant. Brain tumor arises from brain tissue and rarely spreads. The tumor
eventually compress and damage other structures in the brain. According to American
Brain Tumor Association (ABTA), there are two types of brain tumors - primary and
secondary. Primary tumors arises from brain tissue and secondary tumors arises from
other parts of the body and spreads to brain. Gliomas are most common type of primary
tumors which arises from brain’s glial tissue. Glioblastoma multifome is a fast growing
and of higher grade when compared to other tumors. Advanced medications are
available to treat the brain tumors. Increasing pharmaceutical R&D spending is expected
to provide the lucrative growth for the global brain tumor treatment market over the
forecasted period.
Brain Tumor Treatment Market: Drivers and restraints
Increasing incidence of brain tumor (Glioblastoma) is one of the leading factor driving the
growth of the market globally. For instance, as per the American Society of Clinical
Oncology (ASCO), brain tumor incidence rate growing at 2.6% compared to the last year.
An estimated 22,850 cases diagnosed with primary cancerous tumors of the brain in the
U.S. Furthermore, increasing geriatric population is also driving the brain tumor market.
Increasing consumer awareness regarding the latest technological advancements in
therapies, and medications are responsible for the growth of global brain tumor
treatment market.
Report
Description
Report Description
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1302
Brain Tumor Treatment Market: Segmentation
Global Brain Tumor Treatment Market can be segmented as following types
By Product:
• Temozolomide
• Carmustine
• Cisplatin
• Bevacizumab
• Geftinib
• Erlotinib
By End user:
• Hospital Pharmacies
• Ambulatory Surgical Centers
• Individual Pharmacies
Report
Description
Report Description
Brain Tumor Treatment Market: Overview
Increase in incidence rate of brain tumor has fuelled the demand for effective treatment.
As such, global companies are spending significant portion of their revenue on R&D to
develop novel medications. Many products related to novel drug delivery technologies
are lined up for FDA approval. Increasing demand for advance medication to treat brain
tumors is expected to fuel overall growth of the market.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1302
Brain Tumor Treatment Market: Region-Wise Outlook
Depending upon the geographic regions brain tumor treatment market segmented into
seven key regions: Those are North America, Latin America, and Eastern Europe, Western
Europe, and Asia pacific excluding japan, Japan, Middle East and Africa.
North America and European region is expected to dominate the global brain tumor
market throughout the forecast period, owing to increasing incidences of glioblastoma
coupled with technological advancements.
Though North America and Europe are expected to lead the market, Asia Pacific is
anticipated to witness robust growth. Significant increase in incidence rate of brain
tumors along with shifting of locus of economic activity and dynamism to this region is
expected to boost the demand for drugs responsible for brain tumor treatment.
Report
Description
Report Description
Browse full report: http://www.futuremarketinsights.com/reports/brain-tumortreatment-market
Latin America and MEA are expected to witness moderate growth during the forecast
period. Companies need to capitalize their resources in emerging regions to gain market
share in brain tumor treatment market.
Brain Tumor Treatment Market: Key players
Key players in the brain tumor treatment market are Genetech U.S.A, Bristol Myers
Squibb, Hoffmann- La Roche, AstraZeneca plc, Pfizer, Inc., Novartis AG, Antisense Pharma,
Merck & Co, Macleods Pharmaceutical Limited, Mankind Pharma, Dr. Reddys
Laboratories Ltd.
Thank You!
To know more about us, please visit our website:
www.futuremarketinsights.com
For sales queries or new topics email us on:
[email protected]
For other queries contact: Mr. Sudip Saha
Future Market Insights: 616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
T: +1-347-918-3531 | D: +1-845-579-5705